{
    "id": 32349,
    "fullName": "EGFR A750_I759delinsPT",
    "impact": "indel",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "EGFR A750_I759delinsPT results in a deletion of ten amino acids in the protein kinase domain of the Egfr protein from aa 750 to aa 759, combined with the insertion of a proline (P) and a threonine (T) at the same site (UniProt.org). A750_I759delinsPT has not been biochemically characterized, but is predicted to result in a gain of function based on the effect of other EGFR exon 19 deletion and deletion-insertion mutations (PMID: 19147750, PMID: 22190593, PMID: 23387505).",
            "references": [
                {
                    "id": 1890,
                    "pubMedId": 19147750,
                    "title": "Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19147750"
                },
                {
                    "id": 441,
                    "pubMedId": 23387505,
                    "title": "Sensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23387505"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 439,
                    "pubMedId": 22190593,
                    "title": "EGFR exon 19 insertions: a new family of sensitizing EGFR mutations in lung adenocarcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22190593"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1956,
        "geneSymbol": "EGFR",
        "terms": [
            "EGFR",
            "ERBB",
            "ERBB1",
            "HER1",
            "mENA",
            "NISBD2",
            "PIG61"
        ]
    },
    "variant": "A750_I759delinsPT",
    "createDate": "01/29/2020",
    "updateDate": "01/29/2020",
    "referenceTranscriptCoordinates": {
        "id": 187173,
        "transcript": "NM_005228",
        "gDna": "chr7:g.55174785_55174814delinsCCTACA",
        "cDna": "c.2248_2277delinsCCTACA",
        "protein": "p.A750_I759delinsPT",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20092,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, Tarceva (erlotinib) treatment resulted in a partial response with a progression-free survival of 15 months in a patient with non-small cell lung cancer harboring EGFR A750_I759delinsPT (PMID: 31715539).",
            "molecularProfile": {
                "id": 34866,
                "profileName": "EGFR A750_I759delinsPT"
            },
            "therapy": {
                "id": 4,
                "therapyName": "Erlotinib",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 17697,
                    "pubMedId": 31715539,
                    "title": "Detection of rare and novel EGFR mutations in NSCLC patients: Implications for treatment-decision.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31715539"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34866,
            "profileName": "EGFR A750_I759delinsPT",
            "profileTreatmentApproaches": [
                {
                    "id": 20201,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "EGFR A750_I759delinsPT"
                },
                {
                    "id": 20204,
                    "name": "EGFR Inhibitor (Pan)",
                    "profileName": "EGFR A750_I759delinsPT"
                },
                {
                    "id": 20200,
                    "name": "EGFR Inhibitor 1st gen",
                    "profileName": "EGFR A750_I759delinsPT"
                },
                {
                    "id": 20202,
                    "name": "EGFR Inhibitor 2nd gen",
                    "profileName": "EGFR A750_I759delinsPT"
                },
                {
                    "id": 20203,
                    "name": "EGFR Inhibitor 3rd gen",
                    "profileName": "EGFR A750_I759delinsPT"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 187173,
            "transcript": "NM_005228",
            "gDna": "chr7:g.55174785_55174814delinsCCTACA",
            "cDna": "c.2248_2277delinsCCTACA",
            "protein": "p.A750_I759delinsPT",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}